Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Rejection
100%
Kidney Transplantation
100%
Rejection Episodes
100%
Efficacy Endpoint
100%
Anti-rejection Therapy
50%
Serum Creatinine
33%
Clinical Signs
33%
Clinical Trials
16%
Immunosuppressive Therapy
16%
Pathological Findings
16%
Transplantation
16%
Histological Grade
16%
Patient Demographics
16%
Fever
16%
Nineteen
16%
Biopsy-proven Rejection
16%
Graft Survival
16%
Maintenance Immunosuppression
16%
Kidney Allograft
16%
Acute Rejection Episode
16%
Banff Schema
16%
North America
16%
Transplant Rejection
16%
Creatinine Level
16%
Induction Immunosuppression
16%
International Database
16%
Clinical Trial Design
16%
Demographic Parameters
16%
Drug Dosing
16%
Dose Duration
16%
Protocol Development
16%
Medicine and Dentistry
Acute Graft Rejection
100%
Creatinine
100%
Kidney Transplantation
100%
Clinical Trial
33%
Biopsy Technique
33%
Recurrent Disease
33%
Kidney Allograft
33%
Immunosuppressive Treatment
33%
Graft Survival
33%
Graft Rejection
33%
Clinical Trial Design
33%
Immunology and Microbiology
Creatinine Blood Level
100%
Acute Graft Rejection
100%
Kidney Transplantation
100%
Immunosuppression
50%
Allograft
50%
Transplant Rejection
50%
Drug Dose
50%
Pharmacology, Toxicology and Pharmaceutical Science
Creatinine
100%
Acute Graft Rejection
100%
Clinical Trial
33%
Recurrent Disease
33%
Graft Rejection
33%
Drug Dose
33%
Clinical Trial Design
33%